LYMPHOCYTE CIRCULATION--PLASMACYTOMAGENESIS
LYMPHOCYTE CIRCULATION--PLASMACYTOMAGENESIS
批准号:
3796451
负责人:
S RUDIKOFF
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
B lymphocyte Peyer's patches T cell receptor cancer risk carcinogenesis cell population study cytotoxic T lymphocyte embryo /fetus tissue /cell culture genetic strain genetically modified animals helper T lymphocyte intestinal mucosa laboratory mouse leukocyte adhesion molecules lymph nodes mesentery plasma cell neoplasm receptor expression
中文摘要
BALB/c小鼠对浆细胞瘤(PCT)诱导高度敏感(S)
方案,而DBA/2小鼠具有抗性(R)。 之前我们检查了
通过转移BALB/c或DBA/2骨,
骨髓(BM)注射到SCID小鼠中,并将植烷,
或含有失调的myc和raf癌基因的逆转录病毒J3 V1。 使用
这些诱导方案,我们确定DBA抗性不能被
克服了敏感的SCID微环境,这表明R/S,在
该系统由施主BM规定。 SCID小鼠的最新研究
单独用外周成熟BALB/c淋巴细胞重建,或
与DBA/2 BM共同转让的建议如下:1.)成熟BALB/c B
来自脾、淋巴结或派伊尔集合淋巴结的细胞同样易受
肿瘤诱导; 2.)DBA/2细胞不抑制BALB/c小鼠PCT的发育;
和3.)BALB/c淋巴细胞不能为DBA/2 B细胞提供外源性的
PCT发展所需的细胞信号。 因此,DBA/2抗性和
BALB/c对PCT诱导的易感性是BALB/c小鼠固有的特征,
各自的B细胞。 二. SCID小鼠也被用于研究正常的
淋巴细胞发育和寿命。 此前,我们确定,
Peyer’s patch细胞过继转移给SCID小鼠,
所有淋巴组织的重建,除了胸腺,
仅出现单一阳性的CD 4和CD 8成熟T细胞。 我们扩大
这些研究旨在确定该复溶的持续时间,
外周(PLN)和肠系膜(MLN)淋巴的重建潜力
结细胞 结果表明:1.)PLN细胞重建外周
淋巴器官,但在肠道粘膜的再增殖方面效果较差
组织比Peyer's patch细胞; 3.)PLN和MLN的胸腺
重建的SCID小鼠含有供体CD 4和CD 8单阳性成熟T细胞
细胞;和4.)PP、MLN和PLN的重新填充持续超过6年
个月 这些结果表明,成熟淋巴细胞的寿命
比以前建议的要长。 此外,
这些细胞表明,粘膜和外周淋巴细胞
它们调节归巢受体表达的能力不同,
因此它们的淋巴组织重建模式。
英文摘要
BALB/c mice are highly susceptible (S) to plasmacytoma (PCT) induction
protocols while DBA/2 mice are resistant (R). Previously we examined the
cellular basis for this phenomenon by transferring BALB/c or DBA/2 bone
marrow (BM) to SCID mice and injecting the chimeras with either pristane,
or the retrovirus J3V1 containing deregulated myc and raf oncogenes. Using
these induction protocols we determined that DBA resistance could not be
overcome by the susceptible SCID microenvironment suggesting that R/S, in
this system, is dictated by the donor BM. Recent studies of SCID mice
reconstituted with peripheral, mature BALB/c lymphocytes either alone, or
co-transferred with DBA/2 BM suggest the following: 1.) Mature BALB/c B
cells from spleen, lymph node or Peyer's patches are equally susceptible to
tumor induction; 2.) DBA/2 cells do not suppress BALB/c PCT development;
and 3.) BALB/c lymphocytes can not supply DBA/2 B cells with the extra-
cellular signals required for PCT development. Thus, DBA/2 resistance and
BALB/c susceptibility to PCT induction are traits inherent to the
respective B cells. II. SCID mice have also been used to study normal
lymphocyte development and life-span. Previously, we determined that
adoptive transfer of Peyer's patch cells to SCID mice resulted in normal
reconstitution of all lymphoid tissues except the thymus in which there
appeared only single positive CD4 and CD8 mature T cells. We have expanded
these studies to determine the duration of this reconstitution and the
reconstituting potential of peripheral (PLN) and mesenteric (MLN) lymph
node cells. Results indicate that: 1.) PLN cells reconstitute peripheral
lymphoid organs, but are less effective at repopulation of the gut mucosal
tissues than Peyer's patch cells; 3.) The thymii of PLN and MLN
reconstituted SCID mice contain donor CD4 and CD8 single positive mature T
cells; and 4.) PP, MLN and PLN repopulation persists for greater than 6
months. These results demonstrate that the lifespan of mature lymphocytes
is longer than previously suggested. Moreover, the homing properties of
these cells in SCID mice indicate that mucosal and peripheral lymphocytes
differ in their ability to modulate homing receptor expression and
consequently their pattern of lymphoid tissue reconstitution.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PLASMACYTOMAGENESIS AND LYMPHOCYTE DEVELOPMENT
-
批准号:5200935
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S RUDIKOFF
-
依托单位:
BIOLOGY OF PLASMA CELL TUMOR DEVELOPMENT
-
批准号:6160922
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S RUDIKOFF
-
依托单位:
PLASMACYTOMAGENESIS AND LYMPHOCYTE DEVELOPMENT
-
批准号:3752022
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S RUDIKOFF
-
依托单位:
PLASMACYTOMAGENESIS AND LYMPHOCYTE DEVELOPMENT
-
批准号:3774307
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S RUDIKOFF
-
依托单位:
IMMUNOGLOBULIN STRUCTURE & DIVERSITY--CHARACTERIZATION OF CELL MEMBRANE PROTEINS
-
批准号:3916300
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S RUDIKOFF
-
依托单位:
IMMUNOGLOBULIN STRUCTURE & DIVERSITY--CHARACTERIZATION OF CELL MEMBRANE PROTEINS
-
批准号:3808511
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S RUDIKOFF
-
依托单位:
IMMUNOGLOBULIN STRUCTURE & DIVERSITY--CHARACTERIZATION OF CELL MEMBRANE PROTEINS
-
批准号:3962988
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S RUDIKOFF
-
依托单位:
PLASMACYTOMAGENESIS AND LYMPHOCYTE DEVELOPMENT
-
批准号:2468436
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S RUDIKOFF
-
依托单位:
IMMUNOGLOBULIN STRUCTURE & DIVERSITY--CHARACTERIZATION OF CELL MEMBRANE PROTEINS
-
批准号:4691809
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S RUDIKOFF
-
依托单位:
IMMUNOGLOBULIN STRUCTURE & DIVERSITY--CHARACTERIZATION OF CELL MEMBRANE PROTEINS
-
批准号:3939271
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S RUDIKOFF
-
依托单位:
BIOLOGY OF PLASMA CELL TUMOR DEVELOPMENT
-
批准号:6100822
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S RUDIKOFF
-
依托单位:
IMMUNOGLOBULIN STRUCTURE & DIVERSITY--CHARACTERIZATION OF CELL MEMBRANE PROTEINS
-
批准号:3813344
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S RUDIKOFF
-
依托单位:
海外基金